{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:54:30Z","timestamp":1794412470243,"version":"4.9.0"},"reference-count":26,"publisher":"Japanese Society of Internal Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2019,1,15]]},"DOI":"10.2169\/internalmedicine.1146-18","type":"journal-article","created":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T22:22:18Z","timestamp":1536704538000},"page":"159-166","source":"Crossref","is-referenced-by-count":35,"title":["Randomized Controlled Trial Comparing the Effects of Vonoprazan Plus Rebamipide and Esomeprazole Plus Rebamipide on Gastric Ulcer Healing Induced by Endoscopic Submucosal Dissection"],"prefix":"10.2169","volume":"58","author":[{"given":"Takashi","family":"Ichida","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Tsuchiura Kyodo General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syunsuke","family":"Ueyama","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Tsuchiura Kyodo General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Eto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Tsuchiura Kyodo General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiko","family":"Kusano","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Tsuchiura Kyodo General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Sakai","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Tsuchiura Kyodo General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Ono H, Kondo H, Gotoda T, et al. Endoscopic submucosal dissection for treatment of early gastric cancer. Gut 48: 225-229, 2001.","DOI":"10.1136\/gut.48.2.225"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kakushima N, Yahagi N, Fujishiro M, et al. The healing process of gastric artificial ulcers after endoscopic submucosal dissection. Dig Endosc 16: 327-331, 2004.","DOI":"10.1111\/j.1443-1661.2004.00413.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kakushima N, Fujishiro M, Yahagi N, et al. Helicobactor pylori status and the extent of gastric atorotphy do not affect ulcer healing after endoscopic submucosal dissection. J Gastroenterol Hepatol 21: 1586-1589, 2006.","DOI":"10.1111\/j.1440-1746.2006.04321.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Oh TH, Jung HY, Choi KD, et al. Degree of healing and healing-associated factors of endoscopic submucosal dissection-induced ulcers after pantoprazole therapy for four weeks. Dig Dis Sci 54: 1494-1499, 2009.","DOI":"10.1007\/s10620-008-0506-5"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kato T, Araki H, Onogi F, et al. Clinical trial: rebamipide promotes gastric ulcer healing by proton pump inhibitor after endoscopic submucosal dissection-a randomized controlled study. J Gastroenterol 45: 285-290, 2010.","DOI":"10.1007\/s00535-009-0157-0"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. McKeage K, Blick SK, Croxtall JD, et al. Esomeprazole: a review of its use in the management of gastric acid-related disease in adults. Drugs 68: 1571-1607, 2008.","DOI":"10.2165\/00003495-200868110-00009"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Ichida T, Kusano F, Sakai Y. Effects of esomeprazole on the healing process of post-endoscopic submucosal dissection gastric ulcers: a single arm, prospective trial. J Rural Med 11: 41-45, 2016.","DOI":"10.2185\/jrm.2911"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Sakurai Y, Mori Y, Okamoto H, et al. Acid-inhibitory effects of vonoprazan 20 mg compared with esomeprazole 20 mg or rabeprazole 10 mg in healthy adult male subjects - a randomised open-label cross-over study. Aliment Pharmacol Ther 42: 719-730, 2015.","DOI":"10.1111\/apt.13325"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Tsuchiya I, Kato Y, Tanida E, et al. Effect of vonoprazan on the treatment of artificial gastric ulcers after endoscopic submucosal dissection: prospective randomized controlled trial. Dig Endosc 29: 576-583, 2017.","DOI":"10.1111\/den.12857"},{"key":"10","unstructured":"10. Sakita T, Fukutomi H. Endoscopic diagnosis. In: Ulcer of the Stomach and Duodenum. Yoshitoshi Y, Ed. Nankodo, Tokyo, 1971: 198-208."},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Muto M, Miyamoto S, Hosokawa A, et al. Ensoscopic mucosal resection in the stomach using the insulated needle knife. Endoscopy 37: 178-182, 2005.","DOI":"10.1055\/s-2004-826194"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Hotta K, Oyama T, Akamatsu T, et al. A comparison of outcomes of endoscopic submucosal dissection (ESD) for early gastric neoplasms between high-volume centers and low volume centers: multi-center retrospective questionnaire study conducted by Nagano ESD Study Group. Intern Med 49: 253-259, 2010.","DOI":"10.2169\/internalmedicine.49.2816"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Toyokawa T, Inaba T, Omote S, et al. Risk factors for perforation and delayed bleeding associated with endoscopic submucosal dissection for early gastric neoplasms: analysis of 1123 lesions. J Gastroenterol Hepatol 27: 907-912, 2012.","DOI":"10.1111\/j.1440-1746.2011.07039.x"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Takizawa K, Oda I, Gotoda T, et al. Routine coagulation of visible vessels may prevent delayed bleeding after endoscopic submucosal dissection-an analysis of risk factors. Endoscopy 40: 179-183, 2008.","DOI":"10.1055\/s-2007-995530"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Uedo N, Takeuchi Y, Yamada T, et al. Effect of a proton pump inhibitor or an H2-receptor antagonist on prevention of bleeding from ulcer after endoscopic submucosal dissection of early gastric cancer: a prospective randomized controlled trial. Am J Gastroenterol 102: 1610-1616, 2007.","DOI":"10.1111\/j.1572-0241.2007.01197.x"},{"key":"16","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0016-5085(78)90352-9","volume":"74","author":"FW Green","year":"1978","unstructured":"16. Green FW, Kaplan MM, Curtis LE, et al. Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor to prolonged gastroduodenal mucosal hemorrhage. Gastroenterology 74: 38-43, 1978.","journal-title":"Gastroenterology","ISSN":"https:\/\/id.crossref.org\/issn\/0016-5085","issn-type":"print"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Furuta T, Sugimoto M, Kodaira C, et al. CYP2C19 genotype is associated with symptomatic reccurence of GERD during maintenance therapy with low-dose lansoprazole. Eur J Clin Pharmacol 65: 693-698, 2009.","DOI":"10.1007\/s00228-009-0628-5"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Andersson T, Rohss K, Bredberg E, et al. Pharmacokinetics and pharmacodynamics of esomeprazole, the S-isomer of omeprazole. Aliment Pharmacol Ther 15: 1563-1569, 2008.","DOI":"10.1046\/j.1365-2036.2001.01087.x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Bunno M, Gouda K, Yamahara K, et al. A case-control study of esomeprazole plus rebamipide vs. omeprazole plus rebamipide on post-ESD gastric ulcers. Jpn Clin Med 4: 7-13, 2013.","DOI":"10.4137\/JCM.S11320"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Matsumoto H, Shiotani A, Kastumata R, et al. <i>Helicobacter pylori<\/i> eradication with proton pump inhibitors or potassium-competitive acid blockers: the effect of clarithromycin resistance. Dig Dis Sci 61: 3215-3220, 2016.","DOI":"10.1007\/s10620-016-4305-0"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Cheon JH, Kim JH, Lee SK, et al. <i>Helicobacter pylori<\/i> eradication therapy may facilitate gastric ulcer healing after endoscopic mucosal resection: a prospective randomized study. Helicobacter 13: 564-571, 2008.","DOI":"10.1111\/j.1523-5378.2008.00647.x"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Kobayashi M, Takeuchi M, Hashimoto S, et al. Contributing factors to gastric ulcer healing after endoscopic submucosal dissection including the promoting effect of rebamipide. Dig Dis Sci 57: 119-126, 2012.","DOI":"10.1007\/s10620-011-1850-4"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Ashida K, Sakurai Y, Kudou N, et al. Randomised clinical trial: vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis. Aliment Pharmacol Ther 43: 240-251, 2016.","DOI":"10.1111\/apt.13461"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Tosetti C, Stanghellini V, Tucci A, et al. Gastric emptying and dyspeptic symptoms in patients with nonautoimmune fundic atrophic gastritis. Dig Dis Sci 45: 252-257, 2000.","DOI":"10.1023\/A:1005439905134"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Nakamura K, Ihara E, Akiho H, et al. Limited effect of rebamipide in addition to proton pump inhibitor (PPI) in the treatment of post-endoscopic submucosal dissection gastric ulcers: a randomized controlled trial comparing PPI plus rebamipide combination therapy with PPI monotherapy. Gut Liv 10: 917-924, 2016.","DOI":"10.5009\/gnl15486"},{"key":"26","first-page":"678","volume":"57","author":"T Inaba","year":"2010","unstructured":"26. Inaba T, Ishikawa S, Toyokawa T, et al. Basal protrusion of ulcers induced by endoscopic submucosal dissection (ESD) during treatment with proton pump inhibitors, and the suppressive effects of polaprezinc. Hepatogastroenterology 57: 678-684, 2010.","journal-title":"Hepatogastroenterology","ISSN":"https:\/\/id.crossref.org\/issn\/0172-6390","issn-type":"print"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/2\/58_1146-18\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T02:34:29Z","timestamp":1571884469000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/2\/58_1146-18\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,15]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.1146-18","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,15]]}}}